B-type natriuretic peptide (Teva)

B型利尿钠肽

Report date: 2024/06/27 14:55:09

Base Information

Drug NameB-type natriuretic peptide (Teva)
Drug Alias NameCardevaCG-77X56
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksWikipedia